Expense or Capitalize R&D – SFAS 2 Revisited
Abstract
FASB’s Statement of Financial Accounting Standard No. 2 requires that most of the expenditures incurred in Research and Development Activity be expensed in the period incurred. Expensing a long term asset understates assets and understates true income for a firm in the period, and if R&D activity is material then the users of financial statements are misled into making non-optimal decisions regarding investment and lending to such firms. This paper presents arguments for recording of R&D expenditures as creation of an asset and suggests time periods over which this asset may be amortized. Cross-lagged panel technique is used to infer the direction of causality.
Keywords: Research and Development, causality, cross-lagged panel
To list your conference here. Please contact the administrator of this platform.
Paper submission email: RJFA@iiste.org
ISSN (Paper)2222-1697 ISSN (Online)2222-2847
Please add our address "contact@iiste.org" into your email contact list.
This journal follows ISO 9001 management standard and licensed under a Creative Commons Attribution 3.0 License.
Copyright © www.iiste.org